RxNorm Semantic Concepts Index - 139
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "139".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1390 | Benzethonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1390 | Benzethonium | Designated preferred name (PT) | YES | |
| RxCUI: 1390 | Benzethonium | Full form of descriptor (FN) | YES | |
| RxCUI: 1390 | Benzethonium | Designated preferred name (PT) | YES | |
| RxCUI: 1390 | Benzethonium | Full form of descriptor (FN) | YES | |
| RxCUI: 13904 | N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-glutamic acid | Designated preferred name (PT) | NO | |
| RxCUI: 13904 | N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-glutamic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 13904 | N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-glutamic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 139056 | COMVAX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 139216 | 25-hydroxyvitamin D | Designated preferred name (PT) | NO | |
| RxCUI: 139216 | 25-hydroxyvitamin D | Full form of descriptor (FN) | NO | |
| RxCUI: 139233 | magnesium orotate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 139233 | magnesium orotate | Designated preferred name (PT) | NO | |
| RxCUI: 139233 | magnesium orotate | Full form of descriptor (FN) | NO | |
| RxCUI: 139233 | magnesium orotate | Designated preferred name (PT) | NO | |
| RxCUI: 139233 | magnesium orotate | Full form of descriptor (FN) | NO | |
| RxCUI: 1393087 | aluminum hydroxide / calcium carbonate / magnesium hydroxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1393288 | chymotrypsin / papain / trypsin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 139462 | moxifloxacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 139462 | moxifloxacin | Designated preferred name (PT) | YES | |
| RxCUI: 139462 | moxifloxacin | Full form of descriptor (FN) | YES | |
| RxCUI: 139462 | moxifloxacin | Designated preferred name (PT) | YES | |
| RxCUI: 139462 | moxifloxacin | Full form of descriptor (FN) | YES | |
| RxCUI: 13952 | 3'-nucleotidase | Designated preferred name (PT) | NO | |
| RxCUI: 13952 | 3'-nucleotidase | Full form of descriptor (FN) | NO | |
| RxCUI: 1395721 | Cortalone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 139735 | Licodione O^2'^-methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 139735 | Licodione O^2'^-methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 139749 | Premafloxacin | Designated preferred name (PT) | NO | |
| RxCUI: 139749 | Premafloxacin | Full form of descriptor (FN) | NO | |
| RxCUI: 139778 | tegaserod | Full form of descriptor (FN) | YES | |
| RxCUI: 139778 | tegaserod | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 139778 | tegaserod | Designated preferred name (PT) | YES | |
| RxCUI: 139778 | tegaserod | Full form of descriptor (FN) | YES | |
| RxCUI: 139778 | tegaserod | Designated preferred name (PT) | YES | |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Designated preferred name (PT) | NO | |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Designated preferred name (PT) | NO | |
| RxCUI: 13982 | 3,5,3' triiodothyroacetic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 139825 | Insulin detemir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 139825 | Insulin detemir | Designated preferred name (PT) | YES | |
| RxCUI: 139825 | Insulin detemir | Full form of descriptor (FN) | YES | |
| RxCUI: 139825 | Insulin detemir | Designated preferred name (PT) | YES | |
| RxCUI: 139825 | Insulin detemir | Full form of descriptor (FN) | YES | |
| RxCUI: 139896 | Enfuvirtide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 139896 | Enfuvirtide | Designated preferred name (PT) | YES | |
| RxCUI: 139896 | Enfuvirtide | Full form of descriptor (FN) | YES | |
| RxCUI: 139896 | Enfuvirtide | Designated preferred name (PT) | YES | |
| RxCUI: 139896 | Enfuvirtide | Full form of descriptor (FN) | YES | |
| RxCUI: 1399 | Ethyl aminobenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1399 | Ethyl aminobenzoate | Designated preferred name (PT) | YES | |
| RxCUI: 1399 | Ethyl aminobenzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 1399 | Ethyl aminobenzoate | Designated preferred name (PT) | YES | |
| RxCUI: 1399 | Ethyl aminobenzoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1399 | Ethyl aminobenzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 13995 | 3,3' T>2< | Designated preferred name (PT) | NO | |
| RxCUI: 13995 | 3,3' T>2< | Full form of descriptor (FN) | NO | |
| RxCUI: 13995 | 3,3' T>2< | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 139953 | Pramlintide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 139953 | Pramlintide | Designated preferred name (PT) | YES | |
| RxCUI: 139953 | Pramlintide | Full form of descriptor (FN) | YES | |
| RxCUI: 139953 | Pramlintide | Designated preferred name (PT) | YES | |
| RxCUI: 139953 | Pramlintide | Full form of descriptor (FN) | YES | |
| RxCUI: 139993 | Neumega | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 139994 | Oprelvekin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 139994 | Oprelvekin | Designated preferred name (PT) | YES | |
| RxCUI: 139994 | Oprelvekin | Full form of descriptor (FN) | YES | |
| RxCUI: 139994 | Oprelvekin | Designated preferred name (PT) | YES | |
| RxCUI: 139994 | Oprelvekin | Full form of descriptor (FN) | YES |